Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)
Germany · Delayed Price · Currency is EUR 1.110
+0.020 (1.83%)
At close: Nov 27, 2025
FRA:UJ9 Revenue
Shandong Boan Biotechnology had revenue of 393.41M CNY in the half year ending June 30, 2025, with 50.60% growth. This brings the company's revenue in the last twelve months to 756.78M, up 5.13% year-over-year. In the year 2024, Shandong Boan Biotechnology had annual revenue of 726.32M with 17.50% growth.
Revenue (ttm)
756.78M CNY
Revenue Growth
+5.13%
P/S Ratio
7.79
Revenue / Employee
995.77K CNY
Employees
760
Market Cap
701.10M EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 726.32M | 108.19M | 17.50% |
| Dec 31, 2023 | 618.13M | 102.17M | 19.80% |
| Dec 31, 2022 | 515.96M | 357.26M | 225.11% |
| Dec 31, 2021 | 158.70M | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |